Amy A. Kirkwood

5.0k total citations
85 papers, 2.0k citations indexed

About

Amy A. Kirkwood is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amy A. Kirkwood has authored 85 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 33 papers in Oncology and 26 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amy A. Kirkwood's work include Lymphoma Diagnosis and Treatment (43 papers), Acute Lymphoblastic Leukemia research (26 papers) and Lung Cancer Treatments and Mutations (15 papers). Amy A. Kirkwood is often cited by papers focused on Lymphoma Diagnosis and Treatment (43 papers), Acute Lymphoblastic Leukemia research (26 papers) and Lung Cancer Treatments and Mutations (15 papers). Amy A. Kirkwood collaborates with scholars based in United Kingdom, United States and Australia. Amy A. Kirkwood's co-authors include Tim Meyer, Roopinder Gillmore, Allan Hackshaw, Andrew K. Burroughs, Ayshea Hameeduddin, Sam Stuart, Martyn Caplin, Nick Woodward, Theodora Tsigani and Mohid S. Khan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Amy A. Kirkwood

77 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy A. Kirkwood United Kingdom	24	959	693	542	468	372	85	2.0k
Soon Thye Lim Singapore	27	1.4k 1.5×	1.7k 2.4×	389 0.7×	325 0.7×	187 0.5×	123	2.6k
Leo Mascarenhas United States	28	966 1.0×	512 0.7×	452 0.8×	168 0.4×	72 0.2×	149	3.1k
Marcio H. Malogolowkin United States	37	1.0k 1.1×	285 0.4×	494 0.9×	290 0.6×	1.1k 2.9×	124	4.2k
Noah Federman United States	28	1.0k 1.1×	334 0.5×	355 0.7×	135 0.3×	122 0.3×	142	3.0k
Daryl Tan Singapore	16	696 0.7×	642 0.9×	114 0.2×	143 0.3×	124 0.3×	73	1.4k
Cynthia E. Herzog United States	32	1.0k 1.0×	302 0.4×	366 0.7×	252 0.5×	53 0.1×	91	2.7k
Selim Corbacioglu Germany	29	643 0.7×	176 0.3×	184 0.3×	185 0.4×	107 0.3×	105	2.7k
Tammy O. Utset United States	25	381 0.4×	363 0.5×	92 0.2×	162 0.3×	142 0.4×	43	3.2k
Woodrow Wells Canada	19	894 0.9×	1.3k 1.8×	548 1.0×	216 0.5×	23 0.1×	43	1.9k
Andrea Riccardo Filippi Italy	30	787 0.8×	479 0.7×	177 0.3×	89 0.2×	200 0.5×	172	3.3k

Countries citing papers authored by Amy A. Kirkwood

Since Specialization

Citations

This map shows the geographic impact of Amy A. Kirkwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy A. Kirkwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy A. Kirkwood more than expected).

Fields of papers citing papers by Amy A. Kirkwood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy A. Kirkwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy A. Kirkwood. The network helps show where Amy A. Kirkwood may publish in the future.

Co-authorship network of co-authors of Amy A. Kirkwood

This figure shows the co-authorship network connecting the top 25 collaborators of Amy A. Kirkwood. A scholar is included among the top collaborators of Amy A. Kirkwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy A. Kirkwood. Amy A. Kirkwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Viviani, Simonetta, Chiara Pavoni, Sally F. Barrington, et al.. (2025). Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials. Blood Cancer Journal. 15(1). 165–165.

Khwaja, Jahanzaib, Sriram Ravichandran, Oliver C. Cohen, et al.. (2024). Defining a New “Mayo Stage IIIc” Ultra Poor Risk Category in Systemic AL Amyloidosis: Incorporating Echocardiographic Global Longitudinal Strain to the European Modified Mayo Staging System. Blood. 144(Supplement 1). 890–890.

Kirkwood, Amy A., et al.. (2024). Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients. Scientific Reports. 14(1). 12613–12613.

Luminari, Stefano, Alexander Fosså, Judith Trotman, et al.. (2023). Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial. Journal of Clinical Oncology. 42(1). 13–18. 16 indexed citations

O’Connor, David, Melvin Joy, Amir Enshaei, et al.. (2023). Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL. Blood Advances. 7(23). 7231–7234. 4 indexed citations

Pinder, Christopher L., Thomas A. Fox, Amy A. Kirkwood, et al.. (2023). Humoral and cellular responses to SARS‐CoV‐2 in patients with B‐cell haematological malignancies improve with successive vaccination. British Journal of Haematology. 202(6). 1091–1103. 4 indexed citations

Roddie, Claire, Lorna Neill, Wendy Osborne, et al.. (2023). Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma. Blood Advances. 7(12). 2872–2883. 64 indexed citations

O’Connor, David, Jonas Demeulemeester, Lucía Conde, et al.. (2023). The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 41(19). 3545–3556. 12 indexed citations

Enshaei, Amir, Melvin Joy, Amy A. Kirkwood, et al.. (2023). A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study. Blood Advances. 8(5). 1155–1166. 2 indexed citations

10.

Hoskin, Peter, Caroline Brammer, Martin Robinson, et al.. (2021). 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. The Lancet Oncology. 22(3). 332–340. 62 indexed citations

11.

Creasey, Thomas, Sarra Ryan, Amy A. Kirkwood, et al.. (2021). Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials. Haematologica. 107(9). 2051–2063. 14 indexed citations

12.

Bell, Robert M., Amy A. Kirkwood, Darren Hargrave, et al.. (2020). Disseminated Low Grade Glioma in Children and Young Adults. UCL Discovery (University College London). 6(1). 1 indexed citations

13.

Phillips, Elizabeth H., Catherine Burton, Amy A. Kirkwood, et al.. (2020). Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial. SHILAP Revista de lepidopterología. 1(1). 133–141. 6 indexed citations

14.

Fox, Thomas A., Amy A. Kirkwood, James Day, et al.. (2020). Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy. British Journal of Haematology. 191(2). 194–206. 49 indexed citations

15.

Kirkwood, Amy A., Massimo Federico, Judith Trotman, et al.. (2017). OUTCOMES OF TREATMENT FOR OBESE PATIENTS WITH ADVANCED HODGKIN LYMPHOMA IN THE RATHL TRIAL (CRUK/07/033). Hematological Oncology. 35(S2). 172–172.

16.

Pike, Lucy, Amy A. Kirkwood, Pip Patrick, et al.. (2017). CAN BASELINE PET‐CT FEATURES PREDICT OUTCOMES IN ADVANCED HODGKIN LYMPHOMA? A PROSPECTIVE EVALUATION OF UK PATIENTS IN THE RATHL TRIAL (CRUK/07/033). Hematological Oncology. 35(S2). 37–38. 17 indexed citations

17.

Khan, Mohid S., Amy A. Kirkwood, Theodora Tsigani, et al.. (2015). Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms. Clinical Cancer Research. 22(1). 79–85. 66 indexed citations

18.

Hoskin, Peter, Amy A. Kirkwood, Caroline Brammer, et al.. (2012). FoRT: A Phase 3 Multi-Center Prospective Randomized Trial of Low Dose Radiation Therapy for Follicular and Marginal Zone Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 85(1). 22–22. 4 indexed citations

19.

Khan, Mohid S., Amy A. Kirkwood, Theodora Tsigani, et al.. (2012). Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors. Journal of Clinical Oncology. 31(3). 365–372. 137 indexed citations

20.

Turner, Nicholas C., Sandra J. Strauss, Debashis Sarker, et al.. (2010). Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. British Journal of Cancer. 102(7). 1106–1112. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact